Emerging pharmacological strategies in the fight against cocaine addiction
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Cocaine addiction continues to be an important public health problem worldwide. At present, there are no proven pharmacotherapies for cocaine addiction. The studies reviewed here revealed a number of emerging targets for cocaine pharmacotherapy. First, disulfiram, a medication with dopaminergic effects, reduced cocaine use in a number of clinical trials. Second, GABA medications, tiagabine and topiramate, were found promising in clinical trials. Third, a beta-adrenergic blocker, propranolol, may be effective especially among cocaine-addicted individuals with high withdrawal severity. Fourth, treatment with a stimulant medication, modafinil, has reduced cocaine use. Last, a cocaine vaccine that slows entry of cocaine into the brain holds promise. These promising findings need to be further tested in controlled clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incentives Improve Outcome in Outpatient Behavioral Treatment of Cocaine Dependence
Higgins, S. T. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950070060011 · Cited by 806
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Dackis, C. A., Kampman, K. M., Lynch, K. G., Pettinati, H. M., & O'Brien, C. P. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300600 · Cited by 391 · cited 1×
“Modafinil was recently examined for cocaine pharmacotherapy in 62 cocaine-dependent patients in a double-blind, placebocontrolled trial [73].”
BackgroundIntensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
Tyndall, M. W., Currie, S., Spittal, P., Li, K., Wood, E., O'Shaughnessy, M. V., & Schechter, M. T. (2003) · AIDS · doi:10.1097/00002030-200304110-00014 · Cited by 373 · cited 2×
“In a prospective study with 940 HIV seronegative drug users, 190 individuals contracted HIV infection over a 31-month period [8].”
BackgroundOpponent Process Model and Psychostimulant Addiction
Koob, G. F., Caine, S. B., Parsons, L., Markou, A., & Weiss, F. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00438-8 · Cited by 196 · cited 1×
“Neuroadaptation to long-term cocaine use may include a relative hypofunction of the dopaminergic system [20,21].”
BackgroundGrabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Moeller, F. G., Hassan, S., & Schmitz, J. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300392 · Cited by 185 · cited 1×
“In a recent double-blind randomised clinical trial with methadonemaintained cocaine addicts, sustained-release dextroamphetamine at 30 – 60 mg/day was more effective than placebo or dextroamphetamine 15 – 30 mg/day in reducing cocaine use [76].”
BackgroundThe efficacy of disulfiram: a review of outcome studies
HUGHES, J. C., & COOK, C. C. H. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03370.x · Cited by 162 · cited 1×
“1 Dopamine agonists: disulfiram and amantadine Disulfiram is used for the treatment of alcohol dependence due to the unpleasant symptoms it provokes after ethanol intake, which is attributed to increased acetaldehyde levels due to aldehyde dehydrogenase inhibition by disulfiram [33].”
BackgroundModafinil elicits sympathomedullary activation
Taneja, I., Diedrich, A., Black, B. K., Byrne, D. W., Paranjape, S. Y., & Robertson, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000158267.66763.63 · Cited by 68 · cited 1×
“Modafinil, similar to amphetamines, has been shown to increase sympathoadrenal system activity following clinically used doses in humans [69].”
Background
Cited by
The neurobiology and genetics of impulse control disorders: Relationships to drug addictions
Brewer, J. A., & Potenza, M. N. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.043 · Cited by 511
There and Back Again: A Tale of Norepinephrine and Drug Addiction
Weinshenker, D., & Schroeder, J. P. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301263 · Cited by 350
Madras, B. K., Xie, Z., Lin, Z., Jassen, A., Panas, H., Lynch, L., Johnson, R., Livni, E., Spencer, T. J., Bonab, A. A., et al. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.106583 · Cited by 326
Cognitive enhancement as a treatment for drug addictions
Sofuoglu, M., DeVito, E. E., Waters, A. J., & Carroll, K. M. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.06.021 · Cited by 298
Self-citationEffect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana
Schierenbeck, T., Riemann, D., Berger, M., & Hornyak, M. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.12.004 · Cited by 291
Metadata
- Authors
- Sofuoglu, M., & Kosten, T. R.
- Venue
- Expert Opinion on Emerging Drugs
- Publisher
- Informa Healthcare
- Published
- 2006-02-27
- Volume
- 11
- Issue
- 1
- Pages
- 91-98
- ISSN
- 1472-8214 (ISSN-L)
- 1744-7623
- OpenAlex
- W2067140702
- Cited by
- 102
- References
- 7
- FWCI
- 10.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Emerging pharmacological strategies in the fight against cocaine addiction. https://app.cochat.ai/papers/10.1517/14728214.11.1.91
- The paper
- Sofuoglu, M., & Kosten, T. R. (2006). Emerging pharmacological strategies in the fight against cocaine addiction. Expert Opinion on Emerging Drugs. https://doi.org/10.1517/14728214.11.1.91
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.